Skip to content

Clinical trials

Phase 4 Cardiotoxicity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Phase: Phase 4 Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20111
20161
20181
20212
20231
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Active, not recruiting2
Recruiting2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ottawa Hospital Research Institute2
Dinesh Thavendiranathan1
European Institute of Oncology1
Horus University1
Hospital Sirio-Libanes1
Shiraz University of Medical Sciences1
Silesian Centre for Heart Diseases1
TC Erciyes University1
University of Sao Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity10
Breast Neoplasms5
Heart Failure4
Neoplasms3
Breast Diseases1
Neoplasms, Second Primary1

Trials

Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.